7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Atrial Remodeling D064752 1 associated lipids
Vascular Calcification D061205 1 associated lipids
Angina, Stable D060050 2 associated lipids
Bisphosphonate-Associated Osteonecrosis of the Jaw D059266 1 associated lipids
Osteoporotic Fractures D058866 1 associated lipids
Peripheral Arterial Disease D058729 7 associated lipids
Plaque, Atherosclerotic D058226 7 associated lipids
Peri-Implantitis D057873 1 associated lipids
Primary Myelofibrosis D055728 6 associated lipids
Chronic Periodontitis D055113 1 associated lipids
Osteophyte D054850 2 associated lipids
Hyperphosphatemia D054559 1 associated lipids
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative D054438 1 associated lipids
No-Reflow Phenomenon D054318 2 associated lipids
Acute Coronary Syndrome D054058 11 associated lipids
Hypercalciuria D053565 4 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Fractures, Bone D050723 4 associated lipids
Arteriolosclerosis D050379 1 associated lipids
Atherosclerosis D050197 85 associated lipids
Dyslipidemias D050171 7 associated lipids
Hashimoto Disease D050031 1 associated lipids
Hyperparathyroidism, Primary D049950 1 associated lipids
Diabetes Complications D048909 4 associated lipids
Hypertension, Pregnancy-Induced D046110 2 associated lipids
Scleroderma, Limited D045745 1 associated lipids
Glucose Metabolism Disorders D044882 3 associated lipids
Malnutrition D044342 6 associated lipids
Irritable Bowel Syndrome D043183 8 associated lipids
Mastocytoma D034801 3 associated lipids
Hearing Loss D034381 3 associated lipids
Pulmonary Disease, Chronic Obstructive D029424 16 associated lipids
Spondylarthropathies D025242 1 associated lipids
Spondylarthritis D025241 1 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Coronary Stenosis D023921 6 associated lipids
Carcinoma, Pancreatic Ductal D021441 6 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Multiple Sclerosis, Chronic Progressive D020528 3 associated lipids
Brain Infarction D020520 17 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Lithiasis D020347 2 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Tooth Ankylosis D020254 1 associated lipids
Venous Thrombosis D020246 11 associated lipids
Intracranial Hemorrhage, Traumatic D020198 1 associated lipids
Sleep Apnea, Obstructive D020181 9 associated lipids
Genetic Predisposition to Disease D020022 24 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Hot Flashes D019584 5 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Lee HJ et al. Association between polymorphisms in leptin, leptin receptor, and β-adrenergic receptor genes and bone mineral density in postmenopausal Korean women. 2014 Menopause pmid:23760429
Jun AY et al. Tetrahydrofurofuran-type lignans inhibit breast cancer-mediated bone destruction by blocking the vicious cycle between cancer cells, osteoblasts and osteoclasts. 2014 Invest New Drugs pmid:23673814
Kuroyanagi G et al. Suppression by resveratrol of prostaglandin D2-stimulated osteoprotegerin synthesis in osteoblasts. 2014 Prostaglandins Leukot. Essent. Fatty Acids pmid:24813642
Park K et al. Increased OPG/RANKL ratio in the conditioned medium of soybean-treated osteoblasts suppresses RANKL-induced osteoclast differentiation. 2014 Int. J. Mol. Med. pmid:24248634
El-Hoss J et al. Modulation of endochondral ossification by MEK inhibitors PD0325901 and AZD6244 (Selumetinib). 2014 Bone pmid:24269278
Steffens JP et al. Testosterone regulates bone response to inflammation. 2014 Horm. Metab. Res. pmid:24526374
Hooshmand S et al. The effect of dried plum on serum levels of receptor activator of NF-κB ligand, osteoprotegerin and sclerostin in osteopenic postmenopausal women: a randomised controlled trial. 2014 Br. J. Nutr. pmid:24780728
Park MK et al. Halofuginone ameliorates autoimmune arthritis in mice by regulating the balance between Th17 and Treg cells and inhibiting osteoclastogenesis. 2014 pmid:24782183
Nakamura M et al. [Cytokine-mediated bone resorption]. 2014 Clin Calcium pmid:24870834
Dumnicka P et al. Osteoprotegerin, trail and osteoprotegerin/trail ratio in patients at early phase of acute pancreatitis. 2014 Folia Med Cracov pmid:25648306
Shi W et al. Osteoprotegerin is up-regulated in pancreatic cancers and correlates with cancer-associated new-onset diabetes. 2014 Biosci Trends pmid:25641178
Ma Y et al. Acetylcholine affects osteocytic MLO-Y4 cells via acetylcholine receptors. 2014 Mol. Cell. Endocrinol. pmid:24508663
Wu H et al. Ginsenoside metabolite compound K attenuates inflammatory responses of adjuvant-induced arthritis rats. 2014 Immunopharmacol Immunotoxicol pmid:24450920
Park YJ et al. Prediction of subclinical atherosclerosis by serum osteoprotegerin in premenopausal women with systemic lupus erythematous: correlation of osteoprotegerin with monocyte chemotactic protein-1. 2014 Lupus pmid:24531425
Chen W et al. Arthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone loss. 2014 Proc. Natl. Acad. Sci. U.S.A. pmid:24733914
Hong YY et al. Fibroblasts regulate variable aggressiveness of syndromic keratocystic and non-syndromic odontogenic tumors. 2014 J. Dent. Res. pmid:24972872
Schündeln MM et al. Impairment of bone health in pediatric patients with hemolytic anemia. 2014 PLoS ONE pmid:25299063
Nascimento MM et al. Elevated levels of plasma osteoprotegerin are associated with all-cause mortality risk and atherosclerosis in patients with stages 3 to 5 chronic kidney disease. 2014 Braz. J. Med. Biol. Res. pmid:25296363
Kuroyanagi G et al. Down-regulation by resveratrol of basic fibroblast growth factor-stimulated osteoprotegerin synthesis through suppression of Akt in osteoblasts. 2014 Int J Mol Sci pmid:25290095
Brabnikova-Maresova K et al. Serum sclerostin in high-activity adult patients with juvenile idiopathic arthritis. 2014 Arthritis Res. Ther. pmid:25280749
Yokota K et al. Combination of tumor necrosis factor α and interleukin-6 induces mouse osteoclast-like cells with bone resorption activity both in vitro and in vivo. 2014 pmid:24431283
Polyzos SA et al. Denosumab treatment for juvenile Paget's disease: results from two adult patients with osteoprotegerin deficiency ("Balkan" mutation in the TNFRSF11B gene). 2014 J. Clin. Endocrinol. Metab. pmid:24433001
Inanc M et al. Nuclear factor-kappa B ligand and osteoprotegerin levels in serum and gingival crevicular fluid in patients with bone metastases treated with zoledronic acid. 2014 Med. Oncol. pmid:24448976
Canalis E et al. Nemo-like kinase regulates postnatal skeletal homeostasis. 2014 J. Cell. Physiol. pmid:24664870
Lee EJ et al. PTX3 stimulates osteoclastogenesis by increasing osteoblast RANKL production. 2014 J. Cell. Physiol. pmid:24664887
Tao K et al. Influences of IL-6R antibody on PMMA bone cement-mediated expression of OPG and RANKL in synovial fibroblasts. 2014 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:24710939
Kwan JS et al. Meta-analysis of genome-wide association studies identifies two loci associated with circulating osteoprotegerin levels. 2014 Hum. Mol. Genet. pmid:25080503
Yang X et al. [Preliminary study on the best-exerted force chance in the female menstrual cycle]. 2014 Hua Xi Kou Qiang Yi Xue Za Zhi pmid:25033640
Zhou DA et al. Influence of glucocorticoids on the osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. 2014 BMC Musculoskelet Disord pmid:25027542
Rechenberg DK et al. Periapical fluid RANKL and IL-8 are differentially regulated in pulpitis and apical periodontitis. 2014 Cytokine pmid:25022970
Nogueira AV et al. Biomechanical loading modulates proinflammatory and bone resorptive mediators in bacterial-stimulated PDL cells. 2014 Mediators Inflamm. pmid:24976684
Weichhaus M et al. Osteoprotegerin expression in triple-negative breast cancer cells promotes metastasis. 2014 Cancer Med pmid:24976340
Lis GJ et al. Elevated serum osteoprotegerin is associated with decreased osteoclastic differentiation in stenotic aortic valves. 2014 J. Physiol. Pharmacol. pmid:24930509
Kyvernitakis I et al. Effect of aromatase inhibition on serum levels of sclerostin and dickkopf-1, bone turnover markers and bone mineral density in women with breast cancer. 2014 J. Cancer Res. Clin. Oncol. pmid:24903965
Candido R The osteoprotegerin/tumor necrosis factor related apoptosis-inducing ligand axis in the kidney. 2014 Curr. Opin. Nephrol. Hypertens. pmid:24247823
Khan IS et al. Enhancement of an anti-tumor immune response by transient blockade of central T cell tolerance. 2014 J. Exp. Med. pmid:24752296
Rody WJ et al. Differences in the gingival crevicular fluid composition between adults and adolescents undergoing orthodontic treatment. 2014 Angle Orthod pmid:23687969
Zanotti S et al. Sex and genetic factors determine osteoblastic differentiation potential of murine bone marrow stromal cells. 2014 PLoS ONE pmid:24489784
Aksu F et al. The relation between the levels of osteoprotegerin and the degree of coronary artery disease in patients with acute coronary syndrome and stable angina pectoris. 2014 Kardiol Pol pmid:24469748
Scialla JJ et al. Biomarkers of vascular calcification and mortality in patients with ESRD. 2014 Clin J Am Soc Nephrol pmid:24458076
Ohba T et al. Bisphosphonates inhibit osteosarcoma-mediated osteolysis via attenuation of tumor expression of MCP-1 and RANKL. 2014 J. Bone Miner. Res. pmid:24443409
Bastos MF et al. Impact of caffeine and/or estrogen deficiency on trabecular bone area and healing: a study in rats. 2014 Jan-Feb Int J Oral Maxillofac Implants pmid:24451874
Kelesidis T et al. Role of RANKL-RANK/osteoprotegerin pathway in cardiovascular and bone disease associated with HIV infection. 2014 Jul-Sep AIDS Rev pmid:25102334
Verde ME et al. Effect of Bisphosphonates on the Levels of Rankl and Opg in Gingival Crevicular Fluid of Patients With Periodontal Disease and Post-menopausal Osteoporosis. 2015 Acta Odontol Latinoam pmid:27095621
Li G et al. Curcumin improves bone microarchitecture in glucocorticoid-induced secondary osteoporosis mice through the activation of microRNA-365 via regulating MMP-9. 2015 Int J Clin Exp Pathol pmid:26884838
Li B et al. Expression of OPG, RANKL, and RUNX2 in rabbit periodontium under orthodontic force. 2015 Genet. Mol. Res. pmid:26782591
Schiro A et al. Elevated levels of endothelial-derived microparticles, and serum CXCL9 and SCGF-β are associated with unstable asymptomatic carotid plaques. 2015 Sci Rep pmid:26564003
Mizuno M et al. Reveromycin A Administration Prevents Alveolar Bone Loss in Osteoprotegerin Knockout Mice with Periodontal Disease. 2015 Sci Rep pmid:26561427
Morisawa T et al. Osteoprotegerin is Associated With Endothelial Function and Predicts Early Carotid Atherosclerosis in Patients With Coronary Artery Disease. 2015 Int Heart J pmid:26549398
Beuselinck B et al. RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs. 2015 Br. J. Cancer pmid:26528707
Rewiuk K and Grodzicki T Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation. 2015 Biomed Res Int pmid:26504794
Pesce Viglietti AI et al. Brucella abortus Invasion of Osteocytes Modulates Connexin 43 and Integrin Expression and Induces Osteoclastogenesis via Receptor Activator of NF-κB Ligand and Tumor Necrosis Factor Alpha Secretion. 2015 Infect. Immun. pmid:26459511
Nemeth ZK et al. Serum osteoprotegerin is associated with pulse pressure in kidney transplant recipients. 2015 Sci Rep pmid:26459001
Zhang HL and Jin X Relationship between serum adiponectin and osteoprotegerin levels and coronary heart disease severity. 2015 Genet. Mol. Res. pmid:26400332
Ren H et al. Effects of intermedin on proliferation, apoptosis and the expression of OPG/RANKL/M-CSF in the MC3T3-E1 osteoblast cell line. 2015 Mol Med Rep pmid:26398911
Board-Davies E et al. Oral Mucosal Lamina Propria-Progenitor Cells Exert Antibacterial Properties via the Secretion of Osteoprotegerin and Haptoglobin. 2015 Stem Cells Transl Med pmid:26378260
Kato G et al. The inhibitory effects of a RANKL-binding peptide on articular and periarticular bone loss in a murine model of collagen-induced arthritis: a bone histomorphometric study. 2015 Arthritis Res. Ther. pmid:26373710
Li CW et al. Opg/Rankl mRNA dynamic expression in the bone tissue of ovariectomized rats with osteoporosis. 2015 Genet. Mol. Res. pmid:26345854
Kao SY and Stankovic KM Transactivation of human osteoprotegerin promoter by GATA-3. 2015 Sci Rep pmid:26216189
Kassem A et al. TLR5, a novel mediator of innate immunity-induced osteoclastogenesis and bone loss. 2015 FASEB J. pmid:26207027
Yang H et al. A novel model of bisphosphonate-related osteonecrosis of the jaw in rats. 2015 Int J Clin Exp Pathol pmid:26191212
Pitari MR et al. Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts. 2015 Oncotarget pmid:26160841
Hsu BG et al. High Serum Osteoprotegerin Is Associated with Arterial Stiffness in Kidney Transplant Patients. 2015 Tohoku J. Exp. Med. pmid:26156285
Miao X et al. Nanosecond pulsed electric field inhibits proliferation and induces apoptosis in human osteosarcoma. 2015 J Orthop Surg Res pmid:26148858
Bartosińska J et al. The Assessment of Selected Bone and Cartilage Biomarkers in Psoriatic Patients from Poland. 2015 Mediators Inflamm. pmid:26146462
Ye XH et al. Osteoprotegerin polymorphisms in Chinese Han patients with rheumatoid arthritis. 2015 Genet. Mol. Res. pmid:26125863
Yu SG et al. Ursolic acid derivative ameliorates streptozotocin-induced diabestic bone deleterious effects in mice. 2015 Int J Clin Exp Pathol pmid:26097549
Schmitz F et al. Repurposing an Osteoporosis Drug for β Cell Regeneration in Diabetic Patients. 2015 Cell Metab. pmid:26094892
Kondegowda NG et al. Osteoprotegerin and Denosumab Stimulate Human Beta Cell Proliferation through Inhibition of the Receptor Activator of NF-κB Ligand Pathway. 2015 Cell Metab. pmid:26094891
Telejko B et al. The association of bone turnover markers with pro- and anti-inflammatory adipokines in patients with gestational diabetes. 2015 Ann Agric Environ Med pmid:26094529
Ketlogetswe KS et al. Osteoprotegerin, but Not Receptor Activator for Nuclear Factor-κB Ligand, is Associated With Subclinical Coronary Atherosclerosis in HIV-Infected Men. 2015 J. Acquir. Immune Defic. Syndr. pmid:26090754
Ardeshirpour L et al. OPG Treatment Prevents Bone Loss During Lactation But Does Not Affect Milk Production or Maternal Calcium Metabolism. 2015 Endocrinology pmid:25961842
Reveille JD Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis. 2015 Clin. Rheumatol. pmid:25939520
Bortolin RH et al. Protection against T1DM-Induced Bone Loss by Zinc Supplementation: Biomechanical, Histomorphometric, and Molecular Analyses in STZ-Induced Diabetic Rats. 2015 PLoS ONE pmid:25933189
Wei J et al. Effectiveness of combined salmon calcitonin and aspirin therapy for osteoporosis in ovariectomized rats. 2015 Mol Med Rep pmid:25891179
Su F et al. Enhancement of periodontal tissue regeneration by transplantation of osteoprotegerin-engineered periodontal ligament stem cells. 2015 Stem Cell Res Ther pmid:25888745
Shen Y et al. (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway. 2015 BMC Complement Altern Med pmid:25887296
Duan P et al. Gene polymorphisms in RANKL/RANK/OPG pathway are associated with ages at menarche and natural menopause in Chinese women. 2015 BMC Womens Health pmid:25884698
Warren JT et al. Correlating RANK ligand/RANK binding kinetics with osteoclast formation and function. 2015 J. Cell. Biochem. pmid:25864714
Kim KR et al. 15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss. 2015 PLoS ONE pmid:25859665
Wu C et al. Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin. 2015 Genes Dev. pmid:25846796
Åšwierkot J et al. Assessment of the Effect of Methotrexate Therapy on Bone Metabolism in Patients with Rheumatoid Arthritis. 2015 Arch. Immunol. Ther. Exp. (Warsz.) pmid:25837853
Hassan SH et al. Effect of periodontal surgery on osteoprotegerin levels in gingival crevicular fluid, saliva, and gingival tissues of chronic periodontitis patients. 2015 Dis. Markers pmid:25814780
Folestad A et al. Role of Wnt/β-catenin and RANKL/OPG in bone healing of diabetic Charcot arthropathy patients. 2015 Acta Orthop pmid:25811776
Sutton KM et al. The functions of the avian receptor activator of NF-κB ligand (RANKL) and its receptors, RANK and osteoprotegerin, are evolutionarily conserved. 2015 Dev. Comp. Immunol. pmid:25796577
Zheng Y et al. Mesenchymal dental pulp cells attenuate dentin resorption in homeostasis. 2015 J. Dent. Res. pmid:25762594
Dale MD et al. Bone-remodeling transcript levels are independent of perching in end-of-lay white leghorn chickens. 2015 Int J Mol Sci pmid:25625518
Ottewell PD et al. OPG-Fc inhibits ovariectomy-induced growth of disseminated breast cancer cells in bone. 2015 Int. J. Cancer pmid:25603921
Son GY et al. Hypotonic stress induces RANKL via transient receptor potential melastatin 3 (TRPM3) and vaniloid 4 (TRPV4) in human PDL cells. 2015 J. Dent. Res. pmid:25595364
Oostra DR et al. Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer. 2015 Mol. Cell. Endocrinol. pmid:25575458
Majerczyk M et al. [Osteoprotegerin as a marker of atherosclerosis and a prognostic factor in stroke]. 2015 Postepy Hig Med Dosw (Online) pmid:27259222
Fu Y et al. Involvement of the Ca²⁺ signaling pathway in osteoprotegerin inhibition of osteoclast differentiation and maturation. 2015 J. Vet. Sci. pmid:25549213
Lin TH et al. NF-κB decoy oligodeoxynucleotide enhanced osteogenesis in mesenchymal stem cells exposed to polyethylene particle. 2015 Tissue Eng Part A pmid:25518013
Kadlub N et al. The calcineurin inhibitor tacrolimus as a new therapy in severe cherubism. 2015 J. Bone Miner. Res. pmid:25491283
Rao M et al. Osteoclasts are dispensable for hematopoietic progenitor mobilization by granulocyte colony-stimulating factor in mice. 2015 Exp. Hematol. pmid:25461255
Estanislau IM et al. Pleiotropic effects of statins on the treatment of chronic periodontitis--a systematic review. 2015 Br J Clin Pharmacol pmid:25444240
Recker EN et al. A cross-sectional assessment of biomarker levels around implants versus natural teeth in periodontal maintenance patients. 2015 J. Periodontol. pmid:25269523
Meijome TE et al. GATA-1 deficiency rescues trabecular but not cortical bone in OPG deficient mice. 2015 J. Cell. Physiol. pmid:25205203
Solberg LB et al. Tartrate-resistant acid phosphatase (TRAP) co-localizes with receptor activator of NF-KB ligand (RANKL) and osteoprotegerin (OPG) in lysosomal-associated membrane protein 1 (LAMP1)-positive vesicles in rat osteoblasts and osteocytes. 2015 Histochem. Cell Biol. pmid:25201349
Hung JY et al. Tricetin, a dietary flavonoid, suppresses benzo(a)pyrene‑induced human non‑small cell lung cancer bone metastasis. 2015 Int. J. Oncol. pmid:25738754

Table of Content